Document is current
Any future updates will be listed below
-
Authors
Ralf, Ewert
Heine, Alexander
Obst, Anne
Koerner, Karoline
Hustig-Kittler, Veit
Boesche, Michael
Elhadad, Mohamed
Stubbe, Beate
Westhoff, Michael
-
Funding
Funding for this research was provided by:
Universitätsmedizin Greifswald
- License Information
-
More Information
Article History
Received: 1 July 2022
Accepted: 20 April 2023
First Online: 21 April 2023
Competing interests
: RE: Honoraria for scientific lectures from Actelion, GSK, United Therapeutics, AstraZeneca, Novartis, Berlin Chemie, Boehringer Ingelheim, and OMT, and research funding from Boehringer Ingelheim and Actelion Germany. MW: Honoria for scientific lectures from Löwenstein, Boehringer Ingelheim and Janssen. AH, AO, KK, VHK, MB, ME, BS: No potential conflict of interest to report.
